H.R. 9506

H.R. 9506: To amend the National Artificial Intelligence Initiative Act of 2020 to require the Director of the Office of Science and Technology Policy to establish a prize competition program relating to artificial intelligence, and for other purposes.

Introduced Nicholas Begich (R) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9506 aims to amend the National Artificial Intelligence Initiative Act of 2020 by requiring the Director of the Office of Science and Technology Policy to create a prize competition program focused on advancements in artificial intelligence. This program is likely intended to incentivize innovation and research in the AI field.

Positive Media Summary

Media coverage has highlighted the potential of H.R. 9506 to stimulate innovation in artificial intelligence through competitive incentives. Supporters argue that a prize competition could attract talented researchers and businesses, fostering a collaborative environment that accelerates AI development for beneficial applications.

Negative Media Summary

Critics of H.R. 9506 have expressed concerns regarding the feasibility and effectiveness of a prize competition program. Some argue that it may divert funding from more direct investments in AI research and development, and others worry that it could lead to a focus on short-term gains rather than long-term advancements in technology.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Science, Technology, Communications

The analysis of H.R. 9506 reveals no direct industry overlaps between the bill's subject matter, which focuses on artificial intelligence, and the sponsor Nicholas Begich's top donor industries. While there is significant lobbying activity in the policy area related to artificial intelligence, the amounts disclosed do not indicate a direct financial influence on the bill's content. For instance, Vertex Pharmaceuticals has contributed $60,000, but their interests do not directly align with the artificial intelligence initiatives outlined in the bill. Furthermore, several other contributors have undisclosed amounts, making it difficult to assess their potential influence. Overall, the lack of direct financial ties suggests a low risk of conflict of interest.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
SANOFI U.S. SERVICES, INC. MARSHALL & POPP, LLC $60,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed
SAPPHIRE DIGITAL MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Nicholas Begich, ranked by total contributions.

Health Professionals $240,000,000
Individuals: $240,000,000 PACs: $0
Retired $75,000,000
Individuals: $75,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us